TRILLIUM ASSET MANAGEMENT, LLC has added 44,490 shares of $EHC to their portfolio, per a new SEC 13F filing. This disclosure reflects the funds' holdings for the 06-30-2025 report period. You can see the fund's full portfolio on Quiver Quantitative, and also track the largest institutional owners of $EHC.
ENCOMPASS HEALTH Hedge Fund Activity
We have seen 267 institutional investors add shares of ENCOMPASS HEALTH stock to their portfolio, and 264 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- CONGRESS ASSET MANAGEMENT CO added 755,862 shares (+inf%) to their portfolio in Q2 2025, for an estimated $92,691,357
- MASSACHUSETTS FINANCIAL SERVICES CO /MA/ removed 743,967 shares (-67.0%) from their portfolio in Q1 2025, for an estimated $75,348,977
- BLACKROCK, INC. added 587,947 shares (+6.0%) to their portfolio in Q1 2025, for an estimated $59,547,272
- CITADEL ADVISORS LLC added 506,139 shares (+116.6%) to their portfolio in Q1 2025, for an estimated $51,261,757
- T. ROWE PRICE INVESTMENT MANAGEMENT, INC. added 424,691 shares (+25.6%) to their portfolio in Q1 2025, for an estimated $43,012,704
- THRIVENT FINANCIAL FOR LUTHERANS removed 415,726 shares (-46.8%) from their portfolio in Q1 2025, for an estimated $42,104,729
- WELLINGTON MANAGEMENT GROUP LLP removed 411,836 shares (-10.2%) from their portfolio in Q1 2025, for an estimated $41,710,750
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
ENCOMPASS HEALTH Insider Trading Activity
ENCOMPASS HEALTH insiders have traded $EHC stock on the open market 8 times in the past 6 months. Of those trades, 0 have been purchases and 8 have been sales.
Here’s a breakdown of recent trading of $EHC stock by insiders over the last 6 months:
- MARK J TARR (President & CEO) has made 0 purchases and 2 sales selling 118,384 shares for an estimated $14,387,152.
- DOUGLAS E COLTHARP (EVP & Chief Financial Officer) has made 0 purchases and 3 sales selling 43,575 shares for an estimated $5,017,537.
- JOHN PATRICK DARBY (EVP, Gen Counsel & Secretary) sold 10,000 shares for an estimated $1,147,900
- ELISSA JOY CHARBONNEAU (Chief Medical Officer) sold 4,279 shares for an estimated $498,974
- ANDREW L PRICE (Chief Accounting Officer) sold 5,042 shares for an estimated $495,578
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
ENCOMPASS HEALTH Analyst Ratings
Wall Street analysts have issued reports on $EHC in the last several months. We have seen 6 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- Stephens & Co. issued a "Overweight" rating on 06/05/2025
- Keybanc issued a "Overweight" rating on 05/27/2025
- UBS issued a "Buy" rating on 04/28/2025
- RBC Capital issued a "Outperform" rating on 04/28/2025
- Truist Securities issued a "Buy" rating on 04/28/2025
- Barclays issued a "Overweight" rating on 04/25/2025
To track analyst ratings and price targets for ENCOMPASS HEALTH, check out Quiver Quantitative's $EHC forecast page.
ENCOMPASS HEALTH Price Targets
Multiple analysts have issued price targets for $EHC recently. We have seen 7 analysts offer price targets for $EHC in the last 6 months, with a median target of $130.0.
Here are some recent targets:
- Raj Kumar from Stephens & Co. set a target price of $135.0 on 06/05/2025
- Paul Knight from Keybanc set a target price of $135.0 on 05/27/2025
- Andrew Mok from UBS set a target price of $130.0 on 04/28/2025
- Ben Hendrix from RBC Capital set a target price of $125.0 on 04/28/2025
- David Macdonald from Truist Securities set a target price of $135.0 on 04/28/2025
- Andrew Mok from Barclays set a target price of $129.0 on 04/25/2025
Note that there may be inaccuracies in these estimates due to filing errors by the funds, parsing errors by us, or other anomalies.
Check out Quiver Quantitative's $EHC ticker page for more data.
